ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

BACKGROUND: Development of new therapies for Alzheimer's disease (AD) is increasingly focused on more mildly affected populations, and requires new assessment and outcome strategies. Patients in early stages of AD have mild cognitive decline and no, or limited, functional impairment. To respond...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol Neurosurg Psychiatry
Egile Nagusiak: Wang, Jinping, Logovinsky, Veronika, Hendrix, Suzanne B, Stanworth, Stephanie H, Perdomo, Carlos, Xu, Lu, Dhadda, Shobha, Do, Ira, Rabe, Martin, Luthman, Johan, Cummings, Jeffrey, Satlin, Andrew
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2016
Gaiak:
Neurodegeneration
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013117/
https://ncbi.nlm.nih.gov/pubmed/27010616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-312383
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak